Início › Doença Falciforme › Illinois
Ensaios clínicos de Doença Falciforme em Illinois
19 estudos para Doença Falciforme estão buscando participantes em locais em Illinois.
Cidades em Illinois
Texto oficial do estudo (Inglês)
A Study of Nicotinamide With Oral Tetrahydrouridine and Decitabine to Treat High Risk Sickle Cell Disease
- University of Illinois at Chicago College of Medicine, Chicago
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT04055818A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
- Uni of Illinois Hospital and HSC, Chicago
RecrutandoFase 3
Idades de 12 a 100 · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT06439082A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
- University of Illinois Hospital and Health Sciences System, Chicago
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT07187973A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
- Univer Of Illinois at Chicago, Chicago
RecrutandoFase 3
Idades 2 e acima · Todos os sexos · Atualizado em 18 de set. de 2026 · NCT06609226A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
- Childrens Hospital of Chicago, Chicago
- Univer Of Illinois at Chicago, Chicago
RecrutandoFase 3
Idades 12 e acima · Todos os sexos · Atualizado em 17 de set. de 2026 · NCT06612268Tocilizumab for Acute Chest Syndrome
- University of Chicago, Chicago
RecrutandoFase 2
Idades 12 e acima · Todos os sexos · Atualizado em 15 de set. de 2026 · NCT05640271A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
- University of Illinois at Chicago Clinical Research Center, Chicago
- University of Illinois Hospital and Health Sciences System - Investigational Drug Services (IDS), Chicago
- University of Illinois Hospital and Health Sciences System, Chicago
RecrutandoFase 2/3
Idades 12 e acima · Todos os sexos · Atualizado em 18 de ago. de 2026 · NCT05431088A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
- Local Institution - 0034, Chicago
RecrutandoFase 1/2Voluntários saudáveis bem-vindos
Idades 18 e acima · Todos os sexos · Atualizado em 18 de ago. de 2026 · NCT06481306ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Rush University Medical Center, Chicago
- Bleeding and Clotting Disorders Institute, Peoria
RecrutandoEstudo observacional
Todas as idades · Todos os sexos · Atualizado em 17 de ago. de 2026 · NCT04398628Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
- University of Illinois at Chicago, Chicago
RecrutandoFase 2
Idades 12 e acima · Todos os sexos · Atualizado em 14 de ago. de 2026 · NCT06699849The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
- University of Illinois-Chicago - College of Medicine- Site Number : 8400054, Chicago
RecrutandoFase 3
Idades de 10 a 65 · Todos os sexos · Atualizado em 29 de jul. de 2026 · NCT06975865Study of HLA-Haploidentical Stem Cell Transplantation to Treat Clinically Aggressive Sickle Cell Disease
- University of Illinois at Chicago, Chicago
RecrutandoFase 2
Idades de 16 a 60 · Todos os sexos · Atualizado em 8 de jul. de 2026 · NCT03121001Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
- Comer Children's Hospital (MRD-HCT), Chicago
RecrutandoEstudo observacional
Idades de 3 a 20 · Todos os sexos · Atualizado em 4 de jun. de 2026 · NCT06941389Sickle Cell Clinical Research and Intervention Program
- Children's Hospital of Illinois at OSF-Saint Francis Medical Center, Peoria
RecrutandoEstudo observacional
Todas as idades · Todos os sexos · Atualizado em 4 de jun. de 2026 · NCT02098863Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin
- University of Illinois Chicago, Sickle Cell Center, Chicago
RecrutandoFase 2
Idades de 18 a 60 · Todos os sexos · Atualizado em 19 de mai. de 2026 · NCT07175051Delivering Patient-Facing Evidence-Based Guidelines Through mHealth to Adults With Sickle Cell Disease
- University of Illinois at Chicago, Chicago
Recrutando
Idades 18 e acima · Todos os sexos · Atualizado em 23 de mar. de 2026 · NCT06919224Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
RecrutandoFase 2
Idades de 2 a 25 · Todos os sexos · Atualizado em 10 de mar. de 2026 · NCT03587272Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
- Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago
Recrutando
Idades de 16 a 30 · Todos os sexos · Atualizado em 7 de jan. de 2026 · NCT06374238Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease
- University of Illinois, Chicago
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 22 de jun. de 2025 · NCT06385886Fonte: ClinicalTrials.gov, dados obtidos em 1 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.